Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone

PHASE3CompletedINTERVENTIONAL
Enrollment

461

Participants

Timeline

Start Date

September 9, 2014

Primary Completion Date

September 20, 2016

Study Completion Date

September 20, 2016

Conditions
Type 2 Diabetes
Interventions
DRUG

Saxagliptin

administered orally once daily

DRUG

Dapagliflozin

administered orally once daily

DRUG

Sitagliptin

administered orally once daily

DRUG

Placebo matching with Saxagliptin

administered orally once daily

DRUG

Placebo matching with Dapagliflozin

administered orally once daily

DRUG

Placebo matching with Sitagliptin

administered orally once daily

Trial Locations (79)

1022

Research Site, Moloto South

1036

Research Site, Budapest

1097

Research Site, Budapest

1460

Research Site, Boksburg North

1818

Research Site, Johannesburg

1829

Research Site, Lenasia

2013

Research Site, Soweto

4032

Research Site, Debrecen

4091

Research Site, Durban

4405

Research Site, Nyíregyháza

5700

Research Site, Gyula

6500

Research Site, Baja

7100

Research Site, Szekszárd

7700

Research Site, Cape Town

20110

Research Site, Manassas

20230

Research Site, Aguascalientes

23452

Research Site, Suffolk

28144

Research Site, Salisbury

28204

Research Site, Charlotte

28557

Research Site, Morehead City

29204

Research Site, Columbia

31217

Research Site, Chihuahua City

33015

Research Site, Miami

33026

Research Site, Pembroke Pines

33134

Research Site, Coral Gables

33135

Research Site, Miami

33140

Research Site, Miami Beach

33174

Research Site, Miami

34684

Research Site, Palm Harbor

34744

Research Site, Kissimmee

37620

Research Site, Bristol

41017

Research Site, Crestview Hills

44130

Research Site, Guadalajara

44160

Research Site, Guadalajara

44670

Research Site, Guadalajara

51503

Research Site, Council Bluffs

53142

Research Site, Kenosha

60634

Research Site, Chicago

62746

Research Site, Cuautla

64460

Research Site, Monterrey

72205

Research Site, Little Rock

73069

Research Site, Norman

75230

Research Site, Dallas

76180

Research Site, North Richland Hills

77081

Research Site, Houston

77504

Research Site, Pasadena

78229

Research Site, San Antonio

80401

Research Site, Golden

85020

Research Site, Phoenix

85206

Research Site, Mesa

85213

Research Site, Mesa

90057

Research Site, Los Angeles

90255

Research Site, Huntington Park

90650

Research Site, Norwalk

90717

Research Site, Lomita

90723

Research Site, Paramount

91325

Research Site, Northridge

91356

Research Site, Tarzana

92648

Research Site, Huntington Beach

92780

Research Site, Tustin

95823

Research Site, Sacramento

120203

Research Site, Buzău

200349

Research Site, Craiova

300736

Research Site, Timișoara

410169

Research Site, Oradea

440055

Research Site, Satu Mare

500269

Research Site, Brasov

800098

Research Site, Galati

15-879

Research Site, Bialystok

80-546

Research Site, Gdansk

31-156

Research Site, Krakow

31-261

Research Site, Krakow

45-367

Research Site, Opole

61-655

Research Site, Poznan

02-507

Research Site, Warsaw

50-349

Research Site, Wroclaw

51-685

Research Site, Wroclaw

011794

Research Site, Bucharest

020359

Research Site, Bucharest

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY